Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Barr granted approval for generic Aredia injection
The company plans to launch its product in the fourth quarter of calendar 2008. With this approval, Barr’s US generic injectable portfolio now totals eight products.
The company plans to launch its product in the fourth quarter of calendar 2008. With this approval, Barr’s US generic injectable portfolio now totals eight products.
According to the company, True2go offers patients the convenience of anywhere, on-the-go testing to help them better manage their diabetes, while Trueresult offers patients advanced monitoring capabilities at
The shares of common stock sold to the investors represent a 10% interest in the company. The company has also announced the conversion to the company’s common stock
The first patient enrolled in the study was treated by Lyudmila Bazhenova, the trial’s principal investigator at the University of California, San Diego School of Medicine. The study
Arpida is seeking approval of intravenous iclaprim in the EU for the treatment of complicated skin and soft tissue infections (cSSTI). Iclaprim is a hospital antibiotic drug candidate
Hoya’s vision care division will acquire 100% of the shares in Dioptra CZ. While the existing management team will remain in place, Rainer Burkard, director of global business
Net income for the fourth quarter was $65.5 million, compared with a net loss of $7.8 million in the fourth quarter last year. Earnings per share for the
Kenneth Rice, Jr, CFO of Alseres, said: “With the lease for the Hopkinton and Woburn offices expiring concurrently, we decided to consolidate our offices under one roof. The
According to the terms of the agreement, effective July 1, 2008, all future royalty and a potential milestone payment related to Fenoglide in North America due to LifeCycle
The new approach to cancer immunotherapy is expected to achieve increased efficacy compared to the method which Medinet has been providing. In August 2007, both parties signed an